Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001836735 | SCV002097434 | pathogenic | not provided | 2022-11-29 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24726473, 33726816, 35627109) |
3billion | RCV002283456 | SCV002573018 | likely pathogenic | Gordon syndrome | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.97). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with PIEZO2 -related disorder (ClinVar ID: VCV000137630 / PMID: 24726473). The variant has been previously reported as assumed (i.e. paternity and maternity not confirmed) de novo in at least one similarly affected unrelated individual (PMID: 24726473). Different missense changes at the same codon (p.Arg2799Gly, p.Arg2799His) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000137629 , VCV000973945). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. |
OMIM | RCV000125479 | SCV000168931 | pathogenic | Marden-Walker syndrome | 2014-05-01 | no assertion criteria provided | literature only | |
University of Washington Center for Mendelian Genomics, |
RCV000125479 | SCV000281718 | pathogenic | Marden-Walker syndrome | 2014-06-04 | no assertion criteria provided | research |